- Reported transaction lines
- 20
- Buy lines
- 11
- Sell lines
- 9
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-1120
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 7325577 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.44, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-13 | 2026-11-13 | ≈ $2,515,108.65 2,187,051 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 9512628 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.54, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-12 | 2026-11-13 | ≈ $1,010,781.20 706,840 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 10219468 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.65, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-11 | 2026-11-13 | ≈ $139,678.77 86,757 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 10306225 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-09 | 2026-11-13 | ≈ $79,600.00 40,000 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 10266225 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.96 to $2.18, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-09 | 2026-11-13 | ≈ $214,155.54 103,959 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 10370184 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.56, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-06 | 2026-11-13 | ≈ $599,421.56 250,804 shares/units | SEC 4 |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 2529436 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-13 | 2026-11-13 | ≈ $236,917.44 58,068 shares/units | SEC 4 |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 2587504 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.95, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The filing of this Form 4 constitutes an exit filing for the Reporting Person. | 2026-11-12 | 2026-11-13 | ≈ $508,877.40 109,436 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Original filed 2026-11-12 Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 6391 · SEC code covers open-market or private transactions · The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer. · This Form 4/A is being filed solely to indicate that the Reporting Person is no longer subject to Section 16 reporting obligations and constitutes an exit filing for the Reporting Person. | 2026-11-11 | 2026-11-13 | 1,391 shares/units | SEC 4/A Amendment |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 2696940 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.82 to $5.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-11 | 2026-11-12 | ≈ $372,977.45 71,315 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 6391 · SEC code covers open-market or private transactions · The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer. | 2026-11-11 | 2026-11-12 | 1,391 shares/units | SEC 4 |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 2625625 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-10 | 2026-11-10 | ≈ $37,267.10 7,085 shares/units | SEC 4 |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 2618540 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.26 to $7.00, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. | 2026-11-09 | 2026-11-10 | ≈ $53,975.00 8,500 shares/units | SEC 4 |
| Chernett Jorey 10% owner · EXAGEN INC. | XGN EXAGEN INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 2610040 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $5.86 to $6.18, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · This amount corrects a clerical error in the Reporting Person's previously filed Form 4 in which the number of shares beneficially owned by the Reporting Person was under-reported by 2,765 shares. | 2026-11-06 | 2026-11-10 | ≈ $69,167.10 11,265 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Call Option (STLN 21MAY27 $5C) · Derivative security · Direct ownership · Reported balance after transaction: 7000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-10 | 2026-11-10 | 7,000 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Call Option (STLN 19FEB27 $5C) · Derivative security · Direct ownership · Reported balance after transaction: 7500 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased. | 2026-11-09 | 2026-11-10 | 7,500 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 5000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-06 | 2026-11-10 | 5,000 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Call Option (STLN 20NOV26 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 10000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-06 | 2026-11-10 | 10,000 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 7858091 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. | 2026-11-09 | 2026-11-10 | ≈ $176,273.10 48,294 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 7809797 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. | 2026-11-06 | 2026-11-10 | ≈ $11,375,733.39 2,851,061 shares/units | SEC 4 |
| Chernett Jorey 10% owner · Neuronetics, Inc. | STIM Neuronetics, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 10620988 · SEC code covers open-market or private transactions | 2026-10-30 | 2026-11-02 | ≈ $40,860.00 18,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.